According to the Consensus Recommendation on Immunization
2012 [1] the Committee recommends birth dose of OPV, three
primary doses of IPV at 6, 10 and 14 weeks, followed by two
doses of OPV at 6 and 9 months. It further states that since
IPV administered to infants in EPI schedule (i.e., 6
weeks, 10 weeks and 14 weeks) results in suboptimal
seroconversion, hence a supplementary dose of IPV is
recommended at 15-18 months. Will administration of two
doses of OPV not enhance the levels of antibodies generated
by three doses of IPV so that supplementary dose of IPV at
15-18 months be eliminated?
The Committee further states that there
is considerable evidence to show that sequential schedules
that provide IPV first followed by OPV can prevent VAPP
while maintaining the critical benefits conferred by OPV (i.e.,
high levels of gut immunity). In case subsequent
administration of OPV is to provide ‘critical benefit of gut
immunity’, it would be interesting to know the reasons why
children from the countries which have switched over to IPV
only are being deprived of ‘critical benefit of gut
immunity’.